Literature DB >> 22126207

Epigenetic regulation of HIV-1 transcription.

Manoj Kumar Tripathy1, Wasim Abbas, Georges Herbein.   

Abstract

After entry into the target cell and reverse transcription, HIV-1 genes are integrated into the host genome. It is now well established that the viral promoter activity is directly governed by its chromatin environment. Nuc-1, a nucleosome located immediately downstream of the HIV-1 transcriptional initiation site directly impedes long-terminal repeat (LTR) activity. Epigenetic modifications and disruption of Nuc-1 are a prerequisite to the activation of LTR-driven transcription and viral expression. The compaction of chromatin and its permissiveness for transcription are directly dependent on the post-translational modifications of histones such as acetylation, methylation, phosphorylation and ubiquitination. Understanding the molecular mechanisms underlying HIV-1 transcriptional silencing and activation is thus a major challenge in the fight against AIDS and will certainly lead to new therapeutic tools.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126207     DOI: 10.2217/epi.11.61

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  18 in total

1.  H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T Cells.

Authors:  Manoj K Tripathy; Mary E M McManamy; Brandon D Burch; Nancie M Archin; David M Margolis
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

2.  Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.

Authors:  Chuan Li; Hai-Bo Wang; Wen-Dong Kuang; Xiao-Xin Ren; Shu-Ting Song; Huan-Zhang Zhu; Qiang Li; Li-Ran Xu; Hui-Jun Guo; Li Wu; Jian-Hua Wang
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

Review 3.  Eradication of HIV and Cure of AIDS, Now and How?

Authors:  Jielin Zhang; Clyde Crumpacker
Journal:  Front Immunol       Date:  2013-10-18       Impact factor: 7.561

Review 4.  HIV-1 latency in monocytes/macrophages.

Authors:  Amit Kumar; Wasim Abbas; Georges Herbein
Journal:  Viruses       Date:  2014-04-22       Impact factor: 5.048

5.  Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation.

Authors:  Brice J Albert; Austin Niu; Rashmi Ramani; Garland R Marshall; Paul A Wender; Robert M Williams; Lee Ratner; Alexander B Barnes; George B Kyei
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

Review 6.  Epigenetic control of HIV-1 post integration latency: implications for therapy.

Authors:  Amit Kumar; Gilles Darcis; Carine Van Lint; Georges Herbein
Journal:  Clin Epigenetics       Date:  2015-09-24       Impact factor: 6.551

7.  CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.

Authors:  Satinder Dahiya; Yujie Liu; Michael R Nonnemacher; Will Dampier; Brian Wigdahl
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

8.  Transcriptional Gene Silencing (TGS) via the RNAi Machinery in HIV-1 Infections.

Authors:  Gavin C Sampey; Irene Guendel; Ravi Das; Elizabeth Jaworski; Zachary Klase; Aarthi Narayanan; Kylene Kehn-Hall; Fatah Kashanchi
Journal:  Biology (Basel)       Date:  2012-08-24

9.  Epigenome-wide differential DNA methylation between HIV-infected and uninfected individuals.

Authors:  Xinyu Zhang; Amy C Justice; Ying Hu; Zuoheng Wang; Hongyu Zhao; Guilin Wang; Eric O Johnson; Brinda Emu; Richard E Sutton; John H Krystal; Ke Xu
Journal:  Epigenetics       Date:  2016-09-27       Impact factor: 4.528

10.  The variances of Sp1 and NF-κB elements correlate with the greater capacity of Chinese HIV-1 B'-LTR for driving gene expression.

Authors:  Di Qu; Chuan Li; Feng Sang; Qiang Li; Zhi-Qiang Jiang; Li-Ran Xu; Hui-Jun Guo; Chiyu Zhang; Jian-Hua Wang
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.